Wednesday, 29 July 2020
Tuesday, 28 July 2020
Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 447 (TSX: $WEED.TO) (NYSE: $CGC) (NASDAQ: $GNLN) (CSE: $CRFT.C) (OTCQB: $GPFT)
Investor
Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 447 (TSX: $WEED.TO)
(NYSE: $CGC) (NASDAQ: $GNLN) (CSE: $CRFT.C) (OTCQB: $GPFT)
Listen to the podcast:
https://www.investorideas.com/Audio/Podcasts/2020/072820-StocksToWatch.mp3
Read this in full
at https://www.investorideas.com/news/2020/cannabis-potcasts/07281WEED-CGC-GNLN-CRFT-GPFT.asp
Hear Investor ideas cannabis potcast on iTunes
Hear the investor ideas potcast on Spotify
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com
"Potcast" featuring cannabis news, stocks to watch as well as
insights from thought leaders and experts.
In
today’s podcast we look at a few public company announcements.
Canopy
Growth Corporation (TSX:
WEED) (NYSE:
CGC),
a world-leading diversified cannabis, hemp, and cannabis device company, announced the launch
of its new U.S. e-commerce website: ShopCanopy.com.
ShopCanopy serves as the online home
for Canopy Growth's growing portfolio of U.S. hemp-derived CBD product lines,
and a one-stop shop for over 25 product SKUs from brands such as First &
Free, This Works, and BioSteel. The site will continue to feature new brands
from Canopy Growth, including the highly anticipated launch of Martha Stewart
CBD.
"We're pleased to offer our
customers a convenient, one-stop destination for exploring and purchasing Canopy
Growth's products in the U.S.," said Sol Clahane, Vice President and
General Manager – US Region, Canopy Growth. "As our exciting portfolio of
hemp-based CBD products continues to grow and diversify, it's our ambition to
offer competitively-priced, high quality products for each consumer need state
and price point."
The intuitive, easy-to-navigate site
allows consumers to search by brand or product category, such as softgels,
oils, topicals or sport. ShopCanopy also features a robust educational component
with more than 75 FAQs, blog posts and informative CBD educational material.
The content provides consumers with an accessible, transparent, and trustworthy
resource for science-backed information on CBD safety, dosing, benefits,
product quality and more.
"We know consumers are looking
for products they can trust in the nascent CBD industry," continued
Clahane. As an industry leader, we see an opportunity to build brand loyalty by
dealing directly with consumers through an e-commerce platform that brings
Canopy Growth's entire product portfolio together in one place for the first
time."
Canopy Growth is committed to
selling only high-quality, tested and reliable products, and ensuring it makes
no claims unless clinically validated. Every product sold on ShopCanopy will be
accompanied by a Certificate of Analysis, which provides consumers with a
complete list of third-party verified ingredients and testing to certify
precise and accurate labeling of cannabinoid content, purity and safety. Canopy Growth only sells CBD products in
states where it is permissible under state law in order to ensure compliance
with state consumer protection mandates and following the most stringent state
laws regarding sale of CBD. The Company is also abiding by existing FDA
regulations for manufacturing, labeling and marketing dietary supplements.
For more information, or to
purchase* Canopy Growth products, visit www.shopcanopy.com.
Greenlane
Holdings, Inc. (NASDAQ:
GNLN), one of the largest global sellers of premium
cannabis accessories, child-resistant packaging, and specialty vaporization
products, today announced the
launch of VIBES™ Cubano Cones and a new VIBES apparel collection featuring six
unique designs across 25 items. VIBES Fine Rolling Papers is a joint venture
between Greenlane and Berner the extremely influential rapper, serial
entrepreneur, and founder of Cookies. Cultivated and crafted in France, and
then cut and kitted in the Dominican Republic, VIBES offers a curated
assortment of premium cones, rolling paper and branded accessories with a
mission to create the ultimate smoking experience for connoisseurs.
“We created and curated VIBES papers
for the connoisseur with the goal of bringing true innovation to the industry.
With the introduction of The Cubano, we have innovated upon the standard width
and size of a traditional cone. We believe The Cubano uniquely compliments our
generation, culture, and my cannabis brand: Cookies. I couldn’t be more excited
to roll out The Cubano globally,” said Berner, CEO and Co-Founder of VIBES
Rolling Papers.
The Cubano Cone is longer than a
king size paper and significantly wider in diameter. Each cone is meticulously
hand rolled with a structure capable of maintaining its shape when packed while
the draft angle ensures it burns consistently all the way through. The Cubano
is available in all three VIBES paper blends, Ultra Thin, Hemp, and Rice, and
can hold up to 8 grams of dry material. As with all VIBES paper products, The
Cubano uses all-natural acacia tree gum for a perfect seal. They are currently
available in limited quantities through select authorized retailers, and
vibespapers.com.
VIBES launched in 2019 and has
gained a strong reputation for producing superior quality papers and connecting
with consumers in an authentic way. VIBES apparel and accessories have allowed
the company to make the jump from rolling papers to establishing itself as a
genuine lifestyle brand.
In addition to its new Cubano Cones,
VIBES will drop a new apparel collection on its website VibesPapers.com on
Friday, July 31st.The collection consists of six new designs: GOAT, Cheetah,
3D, Joint Cloud, Queen, and Block spread across 25 items including shirts,
hoodies, sweatshirts, fleece pants, and more. The featured graphics were crowd
sourced through VIBES’ Instagram art contest held earlier this year in March.
This new apparel collection expands on VIBES’ line of premium branded
accessories. Visit VibesPapers.com after Friday, July 31st, to shop these
products and more.
BC
Craft Supply Co. Ltd. (CSE:
CRFT) announced its
first purchase of premium artisanal organic cannabis. BC Craft has purchased 29kg of BC Original
Glue, which is pure organic, hand-trimmed, dried flower produced by Coast
Mountain Cannabis. The flower will be packaged in beautiful 3.5 gram jars and
in premium pre-rolls. BC Craft partnered
with Indiva Limited under a master processing agreement (“MPA”) that was
announced on May 13, 2020, to facilitate the processing and sales of premium
cannabis procured through BC Craft’s vast network of artisanal craft
cultivators. Under the MPA, Indiva brings state of the art processing, sales,
and national distribution, which will allow micro and small scale cultivators
access to the national recreational market and greater visibility for their
brand and quality craft product.
BC Craft offers preferential payment
terms for flower, with a 50% deposit and 50% payment within 30 days, thus
allowing the Company to partner with premium small scale craft cultivators
nationwide. BC Craft’s CEO, Matthew Watters stated, “Many of our suppliers have
faced significant challenges when entering the regulated market. We chose these
terms because while it is reasonable and advantageous for the Company, it also
helps the cultivator. Most small batch
cultivators are family run businesses and at BC Craft we believe that they
deserve to be paid on time and at a fair price.”
CMC is a licensed boutique indoor
cultivation facility located in Pemberton, B.C. nestled in the heart of the
British Columbia’s Coast Mountain range. CMC’s team takes great pride in
producing high quality organic cannabis which is reflected in their latest test
results. CMC’s founders have deep roots
in the Sea-to-Sky corridor; they came together with a shared vision and mission
to build a leading edge facility, which respects the traditions of the industry
and grows the best organic cannabis. At
CMC, innovation and sustainability are at the heart of what they do. As champions of their community and the
surrounding environment, they pride themselves on being a craft, ultra-premium
producer, employing the best talent in the industry, and delivering a superior
product and experience to their customers.
Matthew Watters, CEO further stated,
“This is a pivotal moment in BC Craft’s vision and mandate to bring the highest
quality artisanal cannabis into the legal market and serves to validate the
Company's long term business model.”
Zylö
Therapeutics Inc., developer of the transformational Z-pod™
topical delivery platform, announced that it
has entered into an exclusive agreement with Grapefruit USA, Inc. (OTCQB:GPFT) to
supply its Z-pod™ system as the technological underpinning of
Grapefruit’s Hourglass™ time-release cannabinoid topical cream.
Zylö’s patented Z-pod™
system is formulated such that it enables a Patchless Patch™ product
concept, whereby a topically applied cream provides ‘patch-like’ sustained
release of a payload—such as cannabinoids or lidocaine—but without the hassles,
inconvenience, and disposal issues of a patch. With certain payloads, the Z-pod™
delivery system also increases dermal penetration, improves stability, and/or
enhances overall bioavailability.
Grapefruit, which holds licenses in
California and Illinois to manufacture and distribute cannabis products (see www.grapefruitblvd.com), has
exclusivity initially in these two states and has certain rights to expand the
territory of exclusivity to other states and to Canada and Mexico. Canada has a
well-established legalized cannabis marketplace, and it is anticipated that
Mexico will legalize cannabis in the near future.
Grapefruit plans to introduce
Hourglass™ on a limited basis to the California retail market by the
end of the third quarter and to ramp up production and delivery of the product
shortly thereafter. The architecture of the Hourglass™ delivery
cream provides Grapefruit with the ability to formulate variations of its
Hourglass™ product concept by loading the cream with unique blends
of cannabinoids that its customers deem to be efficacious for a given
application or desired result.
Scott Pancoast, Zylö’s CEO and
founder, stated “We are enthusiastic about this partnership with Grapefruit and
believe their Hourglass™ Topical Delivery Cream will be a
game-changer in the recreational/medicinal full-spectrum cannabis market given
the extraordinary advantages over traditional methods of consuming cannabis. We
look forward to a long and expanding relationship with the Grapefruit team.”
Added Bradley J. Yourist,
Grapefruit’s CEO, “We are excited and proud to have completed the developmental
phase of Hourglass™, our breakthrough full-spectrum cannabinoid
time-release topical delivery cream based on Zylö’s patented xerogel silica
delivery system. We have developed an incredible collaborative working relationship
with the Zylö team of scientists, which is evidenced by the scope of our
agreement. We believe that Grapefruit’s Hourglass™ topical delivery
cream is a truly disruptive, breakthrough technology, one that fundamentally
changes the way individuals will use cannabinoids to obtain their unique
benefits. Destructive and socially distasteful smoking of cannabis flowers and
consumption of edibles that are metabolized unevenly are simply no longer
necessary to enjoy both the medicinal and recreational benefits of
cannabinoids. Furthermore, Grapefruit’s Hourglass™ Topical Delivery
Cream offers cannabis users a heretofore unattainable level of discretion and
anonymity. For example, fellow airline, train or ship passengers, concert
goers, and movie or theatre attendees will not be able to detect any telltale
odors normally associated with cannabis use.”
Investor ideas reminds all
listeners to read our disclaimers and disclosures on the Investorideas.com
website and that this podcast is not an endorsement to buy products or services
or securities. Investors are reminded all investment involves risk and possible
loss of investment.
Learn more about
our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
Hear Investor ideas cannabis potcast on iTunes
Hear the investor ideas potcast on Spotify
To hear more Investorideas.com
podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com
podcasts are also available on iTunes,
Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified
word mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that
Inspires Big Investing Ideas
Investorideas.com
is a recognized news source publishing third party news, research and original
financial content. Learn about investing in stocks and sector trends with our
news alerts, articles, podcasts and
videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water,
renewable energy and more. Investor Idea’s original branded content includes
the following podcasts and columns : Crypto Corner , Play
by Play sports and stock news column, Investor Ideas
Potcasts Cannabis News and Stocks on the Move podcast and
column, Cleantech
and Climate Change , Exploring
Mining the AI
Eye .
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other
news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations
of each country. Please read Investorideas.com privacy policy
https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of
cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Follow us on Twitter https://twitter.com/Investorideas
Follow
us on Facebook https://www.facebook.com/Investorideas
Follow
us on YouTube https://www.youtube.com/c/Investorideas
Download
our Mobile App for
iPhone and Android
Join
our Investor Club https://www.investorideas.com/membership/
Contact Investorideas.com
800
665 0411
Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory
Friday, 24 July 2020
Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 446 (TSX: $AVCN.TO) (TSX: $HEXO.TO) (TSX: $ZENA.TO) (OTC: $EHVVF)
Investor
Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 446 (TSX: $AVCN.TO)
(TSX: $HEXO.TO) (TSX: $ZENA.TO) (OTC: $EHVVF)
Delta, Kelowna, BC, July 24, 2020 (Investorideas.com Newswire)
www.Investorideas.com, a global news source covering leading sectors including
marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight
from thought leaders and experts.
Listen to the podcast:
Read this in full
at https://www.investorideas.com/news/2020/cannabis-potcasts/07241AVCN-HEXO-ZENA-EHVVF.asp
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com
"Potcast" featuring cannabis news, stocks to watch as well as
insights from thought leaders and experts.
In
today’s podcast we look at a few public company announcements.
Avicanna
Inc.
(TSX: AVCN) (OTCQX: AVCNF), a biopharmaceutical company
focused on the development, manufacturing and commercialization of
plant-derived cannabinoid-based products, announced that the Company's research
collaborators have received two independent peer-reviewed grants from the
Natural Sciences and Engineering Research Council of Canada. The NSERC Alliance
grants will be used to expand the investigators' collaborative research with
Avicanna.
For the past three years, Dr.
Christine Allen's research group (CARG) in the Leslie Dan Faculty of Pharmacy
at the University of Toronto has supported the development and optimization of
Avicanna's cannabinoid-based products including commercial cosmetics (Pura
H&W) and medical cannabis (Rho Phyto) product lines and the pharmaceutical
pipeline that is currently under clinical investigation. Dr. Allen will now leverage a recent MITACS
award in addition to this NSERC Alliance grant in collaboration with Avicanna
to develop a cannabinoid-based formulation for treatment of COVID-19 related
lung inflammation.
A second NSERC Alliance grant was
awarded to Dr. Jibran Khokhar, Assistant Professor at the University of Guelph,
who has an extensive track-record in behavioural pharmacology and neuroscience.
Avicanna's research program with Dr. Khokhar focuses on evaluating a variety of
cannabinoids in several preclinical models of human psychiatric conditions including
mental health disorders such as anxiety, depression, and PTSD. The NSERC grant
was awarded to evaluate the neurobiological underpinnings of cannabis toxicosis
in a preclinical model, and test the potential efficacy of Avicanna's
naturally-derived cannabinoids and formulations in the treatment of
cannabis-induced toxicosis. With the recent changes in the Canadian regulations
for Cannabis 2.0 allowing for cannabinoid edibles and vapes, there is concern
around an increased risk for adverse events arising from accidental high-dose
cannabis ingestion. Thus, this two-year project will determine the behavioural
and neural correlations of cannabis-induced toxicosis and the effects of
cannabinoids for counteracting cannabis-induced toxicosis.
Dr Jibran Khokhar, commented,
"This research is extremely timely with the new Cannabis 2.0 regulations
and the increased risk for cannabis-induced toxicosis. I am thankful to NSERC
and Avicanna for support of this important research that will have an impact in
our understanding of the neurobiological underpinnings of, and provide novel
treatment avenues to treat, adverse events related to high-dose cannabis
exposures."
HEXO
Corp
(TSX: HEXO) (NYSE: HEXO) announced the launch of its line of vape
products to both adult-use and medical consumers, across Canada.
“At HEXO, we pride ourselves in
ensuring our consumers have access to high-quality, reliable and consistent
cannabis products,” said Sebastien St. Louis, CEO and co-founder of HEXO Corp.
“We are thrilled to launch our vape products across Canada as we continue to
focus on innovation and launching additional 2.0 products across all of our
brands.”
Prior to releasing its line of
vapes, the Company conducted testing to evaluate the taste, tolerability of
effects and short-term undesired effects of its proprietary terpene blends.
HEXO’s vape products currently
include three ready-to-use vape pens and four 510-thread cartridges, in popular
strain-inspired terpene blends. HEXO vapes are available across Canada to both
adult-use and medical consumers.
Zenabis
Global Inc. (TSX: ZENA) today announced initial shipments of its Re-Up
510-Threaded Vaporizer line.
This week, Zenabis completed first
shipments of this new product line, which is produced at Zenabis Atholville
using product cultivated and extracted by Zenabis, with no requirement for
third-party processing. Currently, the product offering includes two high THC
products and one CBD product. Zenabis currently has listings of this product in
five provinces and anticipates listings in an additional three provinces by the
end of August.
Zenabis anticipates that its
510-Threaded Vaporizer line will contribute meaningfully to net revenue from
August 2020 onward given consumer preference for the Re-Up 510-Threaded
Vaporizer line of products. Thus far, all offers made under the Re-Up 510
Threaded Vaporizer line have been accepted by provincial counterparties. Zenabis has focused on achieving
differentiation in this product line through:
● A focus
on competitive, best-in-class pricing (targeting lowest retail pricing versus
competitors in all available provincial markets); and
● Products
based on terpene flavour profile, as opposed to cultivar.
Zenabis created this product line
with a focus on consumer education and experience. The Re-Up 510-Threaded
Vaporizer line of products was developed by our product development team to
assist consumers in better understanding the botanical nature of terpenes. Each
vaporizer cartridge type was developed with a purposefully curated selection of
terpenes with complementary flavour profiles and similar characteristics. The
initial launch of the
Re-Up 510-Threaded Vaporizer product
line will include two high THC vaporizer cartridges: (i) Lemon and Lavender;
and (ii) Hops and Spice, as well as one high CBD vaporizer cartridge, Pine and
Berry. The Re-Up 510-Threaded Vaporizers product line will be available in two
formats, 0.5g and 1.0g, and fit all standard 510 thread vaporizer pens.
Kevin Coft, Chief Executive Officer
of Zenabis, stated, "We are very excited to have completed initial
shipments under this product line, especially given that this was achieved
through full, internalized production of these products at Zenabis Atholville
utilizing in-house extraction and filling. We believe that the Re-Up 510-Threaded
Vaporizer line is a strong complement to our existing, premium Pax Era line of
vaporizer cartridges." Olen Vanderleeden, Senior Vice President of Zenabis
added, "Based on indications from provincial counterparties and
considering our competitive pricing, Zenabis anticipates incremental monthly
revenue in excess of one million dollars per month once production at Zenabis
Atholville rises to a level to meet consumer demand."
Ehave,
Inc.
(OTC : EHVVF) and its subsidiary PsyTech announced today an upcoming Psychedelic
Industry webinar for investors and interested individuals. PsyTech was
incubated by iCAN (Israel-cannabis) and developed by the team behind CannaTech,
the premier international cannabis summit. Leveraging the highly relevant
experience of iCAN, PsyTech is positioned to lead the global psychedelic
conversation forward.
Ehave CEO Ben Kaplan said, "Our
PsyTech Conferences have been very popular with investors, as a result of their
insight on the industry. Psychedelic medicine has garnered a tremendous amount
of attentions since The U.S. Food and Drug Administration (FDA) authorized
Breakthrough Therapy Designation to both Compass Pathways' and Usona Institute's
psilocybin therapy for depression in 2018." Mr. Kaplan continued,
"The mainstream media started talking about it late last year after a
group of private donors donated $17 million to start the Center for Psychedelic
and Consciousness Research at Johns Hopkins Medicine. We expect our
complimentary webinar on July 29 will continue our trend of providing important
information on psychedelic medicine to investors.''
The virtual investor webinar titled
Mystical Experience, Religion, and Psychedelics is open to individual
investors, institutional investors, advisors, analysts and the Psychedelic
Community. The program opens at 12:00 PM ET on Wednesday, July 29th.
Speakers for the PsyTech Virtual
Investor Conference include:
Irie Selkirk - Moderator
Director of Rise Wellness Retreat
and Co-Founder of Sansero Life Sciences
Pastor James Lindberg
An Ordained Clergy Person at The
Evangelical Lutheran Church in America
Rabbi Zac Kamenetz
Founder and CEO of Shefa:
Psychedelic Therapy Grounded in Jewish Spirituality
William A. Richards
Psychologist - The Center for
Psychedelic And Consciousness Research At The Johns Hopkins University School
Of Medicine
There are no fees to log-in, or
attend the live presentations.
REGISTER NOW AT
https://www.psytech.biz/psytech-mystical-experience-july-29th/
Please support our partner
organization, Mind Medicine Australia, by registering for their upcoming summit
on psychedelic therapies for mental illness. MMA is offering a special 10%
discount code to the PsyTech community. Just use the code ‘MMA2020’ on their website when purchasing an
event package.
Investor ideas reminds all
listeners to read our disclaimers and disclosures on the Investorideas.com
website and that this podcast is not an endorsement to buy products or services
or securities. Investors are reminded all investment involves risk and possible
loss of investment.
Learn more about
our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
To hear more
Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com
podcasts are also available on iTunes,
Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified
word mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that
Inspires Big Investing Ideas
Investorideas.com
is a recognized news source publishing third party news, research and original
financial content. Learn about investing in stocks and sector trends with our
news alerts, articles, podcasts
and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech,
water, renewable energy and more. Investor Idea’s original branded content
includes the following podcasts and columns : Crypto
Corner , Play by Play sports and stock news column, Investor
Ideas Potcasts Cannabis News and Stocks on the Move podcast and
column, Cleantech and Climate Change , Exploring Mining the AI Eye .
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news,
articles and equity research as well as creates original content, including
video, interviews and articles. Original content created by investorideas is
protected by copyright laws other than syndication rights. Our site does not
make recommendations for purchases or sale of stocks, services or products.
Nothing on our sites should be construed as an offer or solicitation to buy or
sell products or securities. All investing involves risk and possible losses.
This site is currently compensated for news publication and distribution,
social media and marketing, content creation and more. Disclosure is posted for
each compensated news release, content published /created if required but
otherwise the news was not compensated for and was published for the sole
interest of our readers and followers. Contact management and IR of each
company directly regarding specific questions. More disclaimer info:
https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our
other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations
of each country. Please read Investorideas.com privacy policy:
Investor Ideas does not condone the use of
cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Follow us on Twitter https://twitter.com/Investorideas
Follow
us on Facebook https://www.facebook.com/Investorideas
Follow
us on YouTube https://www.youtube.com/c/Investorideas
Download
our Mobile App for
iPhone and Android
Join
our Investor Club https://www.investorideas.com/membership/
Contact Investorideas.com
800
665 0411
Get more Cannabis Stock Investor
Ideas – news, articles, podcasts and stock
directory
Subscribe to:
Posts (Atom)
-
New #Cannabis Stocks Added to Investor Ideas; (TSX: $FAF.V) (CSE: $STIL.C) (CSE: $ORCD.C) (CSE: $VREO.C) (CSE: $PUMP.C) (OTC: $NUGL) ... -
Investor Ideas #Potcasts #Cannabis News and Stocks on the Move: Dixie Brands (CSE: $DIXI_U.C) (OTC: $DXBRF), Khiron Life Sciences (T... -
Investorideas.com - CBD Stock News: InnoCan Pharma (CSE: INNO) Announces the Successful Completion of an Independent Clinical Study Demonstr...